SpringerLink
Log in

Pioglitazone

Hypersensitivity reaction to lactose excipient: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Bryll-Perzan E, et al. A Rare of Adverse Reactions of Pioglitazone: Hypersensitivity to the Active Substance Lactose. Endocrine Practice 27 (Suppl.): S29-S30, No. 6, Jun 2021. Available from: URL: http://doi.org/10.1016/j.eprac.2021.04.532 [abstract]

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pioglitazone. Reactions Weekly 1909, 461 (2022). https://doi.org/10.1007/s40278-022-16748-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-16748-3

Search

Navigation